| Name |
Laennec |
Usage |
Needle Injection |
| MOQ |
1box |
Model No. |
2ml*50 |
| Product status |
Liquid |
Shelf Life |
24months |
Laennec combines ancient traditions and unique modern Japanese technologies.
Modern medicine prefers natural drugs having strong healing effects, lacking side effects and don't building up a tolerance. As a placental biologic drug, Laennec has a polyfunctional effect on all organs and internal systems. Placental therapy allows to increase the phase of active aging, to live a full life at any age and to look great. That's not just a way to cure many illnesses, but also a way to prevent them.
Injection administration of Laennec promotes regeneration and renewal of body cells, supports physiological regeneration and corrects life processes.
Laennec's clinical efficiency and safety is proved by a 55 years long usage in Japanese clinics for treating more than 80 illnesses and by various trials in Russian medical centers: The Burdenko Main Militarys Clinical Hospital, FSBI Federal State Medical and Research Center of the Russian Federation Presidential Administration, FMBA of Russia State Immunology Research Center. Long clinical use of Laennec has proved his efficient hepatoprotective and immunomodulating properties. Laennec was authorized for use in Russia in 2003 as a hepatoprotector and in 2008 as an immune response-modulating agent; product license #013851/01.
Laennec administration normalizes liver biochemical values, improves liver's detoxification and metabolic functions and boosts immune system. The drug revitalizes the body, eliminates fatigue, boosts neural activity and increases tolerance to stress, it is also effective as a treatment of dermatological issues and as a component of esthetic programs.
Dosage and administration for Laennec:
In chronic recurrent herpes and atopic dermatitis, Laennec is injected via IV. 10 ml (560 mg of placental hydrolyzate) of the medicine (5 vials) are dissolved in 250-500 ml of 5% dextrose solution or saline and injected through the ulnar vein for 1.5 -2 h. Injections are carried out 3 times a week with an interval of 2 days. Over all, the course of treatment includes 10 injections.
In chronic liver diseases (steatohepatitis, alcoholic, metabolic, and mixed etiology), the drug is administered intramuscularly at 2 ml / day (112 mg of placental hydrolyzate). Depending on the severity of the disease, the frequency of injections can be increased up to 2-3 times (6 ml) / day. Also the medicine can be injected via IV. 10 ml (560 mg of placentae hydrolyzate) of the drug (5 ampoules) are dissolved in 250-500 ml of 5% dextrose solution or saline and injected through the ulnar vein for 1.5-2 hours. Injections are carried out daily. In that case, the course of treatment is 2-3 weeks.
Audited Supplier 
){kind=link}
){kind=link}